Why the study?
Does serum cholesterol screening and treatment reduce coronary disease incidence and mortality in asymptomatic adults?
Population
Asymptomatic adults (middle-aged men, women, and elderly persons)
Design
Guideline
Authors
Loading...
Supports targeted screening in middle-aged men; confirms coronary benefit without proven overall mortality reduction.
Does serum cholesterol screening and treatment reduce coronary disease incidence and mortality in asymptomatic adults?
Screening for serum cholesterol is recommended every 5 years for asymptomatic, low-risk men, with individualized and optional screening plans for high-risk men, women, and the elderly.
Alan M. Garber (1989) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: